Back to companies

KOREA ARLICO PHARM CO.,LTD.

260660KRKRX

알리코제약

Revenue
₩190.4bn
FY2024
Operating income
-₩5.2bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)